A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study

American Journal of Gastroenterology - United States
doi 10.1038/ajg.2016.482
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Elevated CEA and CA19-9 Serum Levels Independently Predict Advanced Pancreatic Cancer at Diagnosis

Biomarkers
MutagenesisClinical BiochemistryBiochemistryHealthMedicineToxicology
2020English

Prognostic Factors in Pancreatic Cancer: The Role of Perineural, Vascular and Lymphatic Invasion and of Ca19-9

Journal of Gastrointestinal & Digestive System
2013English

Imaging of Primary and Metastatic Pancreatic Cancer Using a Fluorophore-Conjugated Anti-Ca19-9 Antibody for Surgical Navigation

World Journal of Surgery
Surgery
2008English

A Case of Pancreatic Cancer With False‐positive CA19‐9 Result Due to Hyperglycemia Six Years After Pancreaticoduodenectomy

The Japanese Journal of SURGICAL METABOLISM and NUTRITION
2019English

A Case of Ca19-9 Producing Cancer of the Small Intestine With Perforation

The journal of the Japanese Practical Surgeon Society
1995English

CA19–9 Decrease and Survival According to Platelet Level in Patients With Advanced Pancreatic Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer Is Tantamount to Metastatic Disease

Annals of Surgical Oncology
OncologySurgery
2010English

A Case of the Lung Cancer Presented With Abnormally High Serum Ca19-9 Level

The journal of the Japanese Practical Surgeon Society
1990English

Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival

Oncologist
Cancer ResearchMedicineOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy